AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2019

Jun 14, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2019-06-12

Reporting Person: MARAGANORE JOHN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-12	Common stock	G	5000	—	Disposed	32609	Direct

Footnotes

F1: This disposition reflects a gift of 5,000 shares to a not-for-profit organization.